Leonardo D. Di Filippo holds a bachelor degree in Pharmacy-Biochemistry (2019) from the School of Pharmaceutical Sciences at the São Paulo State University (UNESP, Brazil). At the same institution, he obtained a master's degree (2021) and is currently a PhD student enrolled in the postgraduate program in Pharmaceutical Sciences, where he is developing nanostructured formulations for intranasal administration of anti-neoplastic drugs as an alternative for the treatment of brain cancer. His main areas of expertise include pharmaceutical technology, active targeting of nanoparticles, and in vivo models of brain cancer.